Back to
FULLER & THALER ASSET MANAGEMENT, INC.
VIVO
Showing 0 of 18 quarters
Position history for
FULLER & THALER ASSET MANAGEMENT, INC.'s holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Fuller & Thaler Asset Management held 524,904 shares of VIVO (Meridian Bioscience), worth $17.4M. Fuller & Thaler Asset Management's 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings. VIVO was 0.1% of Fuller & Thaler Asset Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.